These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34181481)

  • 1. Fluoroquinolone Prescribing for Diabetic Foot Infections following an FDA Drug Safety Communication for Aortic Aneurysm Risk.
    Li C; Mercuro NJ; Chapin RW; Gold HS; McCoy C
    Antimicrob Agents Chemother; 2021 Aug; 65(9):e0070821. PubMed ID: 34181481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outpatient fluoroquinolone prescribing patterns before and after US FDA boxed warning.
    Bratsman A; Mathias K; Laubscher R; Grigoryan L; Rose S
    Pharmacoepidemiol Drug Saf; 2020 Jun; 29(6):701-707. PubMed ID: 32390266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of FDA black box warning on fluoroquinolone and alternative antibiotic use in southeastern US hospitals.
    Yarrington ME; Anderson DJ; Dodds Ashley E; Jones T; Davis A; Johnson M; Lokhnygina Y; Sexton DJ; Moehring RW
    Infect Control Hosp Epidemiol; 2019 Nov; 40(11):1297-1300. PubMed ID: 31474240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of FDA Boxed Warning on Prescribing Patterns of Fluoroquinolones for Uncomplicated Urinary Tract Infections.
    Cowart K; Worley M; Rouby NE; Sando K
    Ann Pharmacother; 2019 Dec; 53(12):1192-1199. PubMed ID: 31319681
    [No Abstract]   [Full Text] [Related]  

  • 5. Outpatient Fluoroquinolone Prescription Fills in the United States, 2014 to 2020: Assessing the Impact of Food and Drug Administration Safety Warnings.
    Buehrle DJ; Wagener MM; Clancy CJ
    Antimicrob Agents Chemother; 2021 Jun; 65(7):e0015121. PubMed ID: 33875430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Warning for Fluoroquinolone Antibiotics.
    Aschenbrenner DS
    Am J Nurs; 2019 Apr; 119(4):20. PubMed ID: 30896484
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk of Aortic Dissection and Aortic Aneurysm in Patients Taking Oral Fluoroquinolone.
    Lee CC; Lee MT; Chen YS; Lee SH; Chen YS; Chen SC; Chang SC
    JAMA Intern Med; 2015 Nov; 175(11):1839-47. PubMed ID: 26436523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current progress of fluoroquinolones-increased risk of aortic aneurysm and dissection.
    Jun C; Fang B
    BMC Cardiovasc Disord; 2021 Sep; 21(1):470. PubMed ID: 34583637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoroquinolones and the Risk of Aortic Aneurysm or Aortic Dissection: A Systematic Review and Meta-Analysis.
    Rawla P; El Helou ML; Vellipuram AR
    Cardiovasc Hematol Agents Med Chem; 2019; 17(1):3-10. PubMed ID: 30947680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Association of Antibiotic Stewardship With Fluoroquinolone Prescribing in Michigan Hospitals: A Multi-hospital Cohort Study.
    Vaughn VM; Gandhi T; Conlon A; Chopra V; Malani AN; Flanders SA
    Clin Infect Dis; 2019 Sep; 69(8):1269-1277. PubMed ID: 30759198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral Fluoroquinolone and the Risk of Aortic Dissection.
    Lee CC; Lee MG; Hsieh R; Porta L; Lee WC; Lee SH; Chang SS
    J Am Coll Cardiol; 2018 Sep; 72(12):1369-1378. PubMed ID: 30213330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDA adds "black box" warning label to fluoroquinolone antibiotics.
    Tanne JH
    BMJ; 2008 Jul; 337(7662):a816. PubMed ID: 18632714
    [No Abstract]   [Full Text] [Related]  

  • 13. Opportunities to Improve Fluoroquinolone Prescribing in the United States for Adult Ambulatory Care Visits.
    Kabbani S; Hersh AL; Shapiro DJ; Fleming-Dutra KE; Pavia AT; Hicks LA
    Clin Infect Dis; 2018 Jun; 67(1):134-136. PubMed ID: 29373664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic antibiotics for treating diabetic foot infections.
    Selva Olid A; Solà I; Barajas-Nava LA; Gianneo OD; Bonfill Cosp X; Lipsky BA
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD009061. PubMed ID: 26337865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients at Risk for Aortic Rupture Often Exposed to Fluoroquinolones during Hospitalization.
    Frankel WC; Trautner BW; Spiegelman A; Grigoryan L; LeMaire SA
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30478167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluoroquinolones Are Associated With Increased Risk of Aortic Aneurysm or Dissection: Systematic Review and Meta-analysis.
    Vouga Ribeiro N; Gouveia Melo R; Guerra NC; Nobre Â; Fernandes RM; Pedro LM; Costa J; Pinto FJ; Caldeira D
    Semin Thorac Cardiovasc Surg; 2021; 33(4):907-918. PubMed ID: 33181305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of fluoroquinolones use with the risk of aortic aneurysm or aortic dissection: Facts and myths.
    Lai CC; Lu CT; Kao KC; Lu MC; Ko WC; Hsueh PR
    J Microbiol Immunol Infect; 2021 Apr; 54(2):182-184. PubMed ID: 33775552
    [No Abstract]   [Full Text] [Related]  

  • 18. Adverse Events in Older Adults Taking Fluoroquinolones.
    Leipold A; Grupa T; Swanoski M
    Sr Care Pharm; 2020 Aug; 35(8):355-359. PubMed ID: 32718392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outpatient Fluoroquinolone Use in Children, 2000-2018.
    Ross RK; Gerber JS; Willis ZI; Hersh AL; Kinlaw AC
    J Pediatric Infect Dis Soc; 2021 May; 10(5):576-585. PubMed ID: 33377490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concerns About Fluoroquinolones and Aortic Aneurysm.
    Aschenbrenner DS
    Am J Nurs; 2021 May; 121(5):24. PubMed ID: 33872257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.